nodes	percent_of_prediction	percent_of_DWPC	metapath
Lincomycin—Megacolon toxic—Irinotecan—pancreatic cancer	0.0899	0.0899	CcSEcCtD
Lincomycin—Megacolon—Irinotecan—pancreatic cancer	0.0456	0.0456	CcSEcCtD
Lincomycin—Enterocolitis—Docetaxel—pancreatic cancer	0.0186	0.0186	CcSEcCtD
Lincomycin—Abdominal cramps—Tamoxifen—pancreatic cancer	0.0157	0.0157	CcSEcCtD
Lincomycin—Rash pustular—Erlotinib—pancreatic cancer	0.0132	0.0132	CcSEcCtD
Lincomycin—Local reaction—Fluorouracil—pancreatic cancer	0.013	0.013	CcSEcCtD
Lincomycin—Proteinuria—Erlotinib—pancreatic cancer	0.012	0.012	CcSEcCtD
Lincomycin—Protein urine present—Erlotinib—pancreatic cancer	0.0118	0.0118	CcSEcCtD
Lincomycin—Abscess—Sunitinib—pancreatic cancer	0.0115	0.0115	CcSEcCtD
Lincomycin—Abdominal cramps—Irinotecan—pancreatic cancer	0.0111	0.0111	CcSEcCtD
Lincomycin—Vaginal inflammation—Tamoxifen—pancreatic cancer	0.0106	0.0106	CcSEcCtD
Lincomycin—Proteinuria—Sunitinib—pancreatic cancer	0.0103	0.0103	CcSEcCtD
Lincomycin—Protein urine present—Sunitinib—pancreatic cancer	0.0102	0.0102	CcSEcCtD
Lincomycin—Colitis—Erlotinib—pancreatic cancer	0.0101	0.0101	CcSEcCtD
Lincomycin—Vaginal infection—Tamoxifen—pancreatic cancer	0.01	0.01	CcSEcCtD
Lincomycin—Glossitis—Sunitinib—pancreatic cancer	0.00986	0.00986	CcSEcCtD
Lincomycin—Hepatic function abnormal—Tamoxifen—pancreatic cancer	0.00882	0.00882	CcSEcCtD
Lincomycin—Oesophagitis—Sunitinib—pancreatic cancer	0.00831	0.00831	CcSEcCtD
Lincomycin—Proteinuria—Gemcitabine—pancreatic cancer	0.0083	0.0083	CcSEcCtD
Lincomycin—Protein urine present—Gemcitabine—pancreatic cancer	0.00819	0.00819	CcSEcCtD
Lincomycin—Dermatitis bullous—Tamoxifen—pancreatic cancer	0.00806	0.00806	CcSEcCtD
Lincomycin—Dermatitis bullous—Erlotinib—pancreatic cancer	0.00798	0.00798	CcSEcCtD
Lincomycin—Leukocytosis—Fluorouracil—pancreatic cancer	0.00763	0.00763	CcSEcCtD
Lincomycin—Hepatic function abnormal—Sunitinib—pancreatic cancer	0.00755	0.00755	CcSEcCtD
Lincomycin—Colitis—Irinotecan—pancreatic cancer	0.00719	0.00719	CcSEcCtD
Lincomycin—Liver function test abnormal—Tamoxifen—pancreatic cancer	0.00711	0.00711	CcSEcCtD
Lincomycin—Dermatitis bullous—Sunitinib—pancreatic cancer	0.0069	0.0069	CcSEcCtD
Lincomycin—Oesophagitis—Fluorouracil—pancreatic cancer	0.00655	0.00655	CcSEcCtD
Lincomycin—Anorectal discomfort—Epirubicin—pancreatic cancer	0.00639	0.00639	CcSEcCtD
Lincomycin—Abdominal discomfort—Tamoxifen—pancreatic cancer	0.00638	0.00638	CcSEcCtD
Lincomycin—Pancytopenia—Tamoxifen—pancreatic cancer	0.00632	0.00632	CcSEcCtD
Lincomycin—Local reaction—Epirubicin—pancreatic cancer	0.00631	0.00631	CcSEcCtD
Lincomycin—Thrombophlebitis—Irinotecan—pancreatic cancer	0.00628	0.00628	CcSEcCtD
Lincomycin—Vesiculobullous rash—Epirubicin—pancreatic cancer	0.00623	0.00623	CcSEcCtD
Lincomycin—Neutropenia—Tamoxifen—pancreatic cancer	0.00623	0.00623	CcSEcCtD
Lincomycin—Neutropenia—Erlotinib—pancreatic cancer	0.00616	0.00616	CcSEcCtD
Lincomycin—Liver function test abnormal—Sunitinib—pancreatic cancer	0.00609	0.00609	CcSEcCtD
Lincomycin—Hepatic function abnormal—Gemcitabine—pancreatic cancer	0.00606	0.00606	CcSEcCtD
Lincomycin—Thrombophlebitis—Fluorouracil—pancreatic cancer	0.00601	0.00601	CcSEcCtD
Lincomycin—Anorectal discomfort—Doxorubicin—pancreatic cancer	0.00591	0.00591	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Tamoxifen—pancreatic cancer	0.00589	0.00589	CcSEcCtD
Lincomycin—Local reaction—Doxorubicin—pancreatic cancer	0.00584	0.00584	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Erlotinib—pancreatic cancer	0.00582	0.00582	CcSEcCtD
Lincomycin—Vesiculobullous rash—Doxorubicin—pancreatic cancer	0.00576	0.00576	CcSEcCtD
Lincomycin—Stomatitis—Erlotinib—pancreatic cancer	0.00573	0.00573	CcSEcCtD
Lincomycin—Oliguria—Docetaxel—pancreatic cancer	0.00562	0.00562	CcSEcCtD
Lincomycin—Dermatitis bullous—Gemcitabine—pancreatic cancer	0.00554	0.00554	CcSEcCtD
Lincomycin—Abdominal discomfort—Sunitinib—pancreatic cancer	0.00547	0.00547	CcSEcCtD
Lincomycin—Dermatitis bullous—Fluorouracil—pancreatic cancer	0.00545	0.00545	CcSEcCtD
Lincomycin—Pancytopenia—Sunitinib—pancreatic cancer	0.00542	0.00542	CcSEcCtD
Lincomycin—Neutropenia—Sunitinib—pancreatic cancer	0.00533	0.00533	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Sunitinib—pancreatic cancer	0.00504	0.00504	CcSEcCtD
Lincomycin—Erythema multiforme—Tamoxifen—pancreatic cancer	0.00504	0.00504	CcSEcCtD
Lincomycin—Erythema multiforme—Erlotinib—pancreatic cancer	0.00499	0.00499	CcSEcCtD
Lincomycin—Colitis—Docetaxel—pancreatic cancer	0.00497	0.00497	CcSEcCtD
Lincomycin—Stomatitis—Sunitinib—pancreatic cancer	0.00496	0.00496	CcSEcCtD
Lincomycin—Liver function test abnormal—Gemcitabine—pancreatic cancer	0.00489	0.00489	CcSEcCtD
Lincomycin—Oesophagitis—Docetaxel—pancreatic cancer	0.00473	0.00473	CcSEcCtD
Lincomycin—Abscess—Epirubicin—pancreatic cancer	0.00441	0.00441	CcSEcCtD
Lincomycin—Neutropenia—Irinotecan—pancreatic cancer	0.00439	0.00439	CcSEcCtD
Lincomycin—Rash pustular—Epirubicin—pancreatic cancer	0.00438	0.00438	CcSEcCtD
Lincomycin—Phlebitis—Docetaxel—pancreatic cancer	0.00436	0.00436	CcSEcCtD
Lincomycin—Pancytopenia—Gemcitabine—pancreatic cancer	0.00435	0.00435	CcSEcCtD
Lincomycin—Thrombophlebitis—Docetaxel—pancreatic cancer	0.00434	0.00434	CcSEcCtD
Lincomycin—Erythema multiforme—Sunitinib—pancreatic cancer	0.00432	0.00432	CcSEcCtD
Lincomycin—Neutropenia—Gemcitabine—pancreatic cancer	0.00428	0.00428	CcSEcCtD
Lincomycin—Pancytopenia—Fluorouracil—pancreatic cancer	0.00427	0.00427	CcSEcCtD
Lincomycin—Angioedema—Tamoxifen—pancreatic cancer	0.00424	0.00424	CcSEcCtD
Lincomycin—Leukopenia—Tamoxifen—pancreatic cancer	0.00415	0.00415	CcSEcCtD
Lincomycin—Jaundice—Irinotecan—pancreatic cancer	0.00408	0.00408	CcSEcCtD
Lincomycin—Stomatitis—Irinotecan—pancreatic cancer	0.00408	0.00408	CcSEcCtD
Lincomycin—Abscess—Doxorubicin—pancreatic cancer	0.00408	0.00408	CcSEcCtD
Lincomycin—Rash pustular—Doxorubicin—pancreatic cancer	0.00405	0.00405	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Gemcitabine—pancreatic cancer	0.00405	0.00405	CcSEcCtD
Lincomycin—Stomatitis—Gemcitabine—pancreatic cancer	0.00398	0.00398	CcSEcCtD
Lincomycin—Dermatitis bullous—Docetaxel—pancreatic cancer	0.00393	0.00393	CcSEcCtD
Lincomycin—Stomatitis—Fluorouracil—pancreatic cancer	0.00391	0.00391	CcSEcCtD
Lincomycin—Agranulocytosis—Gemcitabine—pancreatic cancer	0.00381	0.00381	CcSEcCtD
Lincomycin—Glossitis—Epirubicin—pancreatic cancer	0.00379	0.00379	CcSEcCtD
Lincomycin—Oliguria—Epirubicin—pancreatic cancer	0.00379	0.00379	CcSEcCtD
Lincomycin—Agranulocytosis—Fluorouracil—pancreatic cancer	0.00374	0.00374	CcSEcCtD
Lincomycin—Shock—Erlotinib—pancreatic cancer	0.00369	0.00369	CcSEcCtD
Lincomycin—Angioedema—Sunitinib—pancreatic cancer	0.00363	0.00363	CcSEcCtD
Lincomycin—Leukopenia—Sunitinib—pancreatic cancer	0.00356	0.00356	CcSEcCtD
Lincomycin—Oliguria—Doxorubicin—pancreatic cancer	0.00351	0.00351	CcSEcCtD
Lincomycin—Glossitis—Doxorubicin—pancreatic cancer	0.00351	0.00351	CcSEcCtD
Lincomycin—Vaginal inflammation—Epirubicin—pancreatic cancer	0.00349	0.00349	CcSEcCtD
Lincomycin—Liver function test abnormal—Docetaxel—pancreatic cancer	0.00347	0.00347	CcSEcCtD
Lincomycin—Erythema multiforme—Gemcitabine—pancreatic cancer	0.00346	0.00346	CcSEcCtD
Lincomycin—Colitis—Epirubicin—pancreatic cancer	0.00335	0.00335	CcSEcCtD
Lincomycin—Vaginal infection—Epirubicin—pancreatic cancer	0.0033	0.0033	CcSEcCtD
Lincomycin—Aplastic anaemia—Epirubicin—pancreatic cancer	0.00328	0.00328	CcSEcCtD
Lincomycin—Pain—Tamoxifen—pancreatic cancer	0.00324	0.00324	CcSEcCtD
Lincomycin—Vaginal inflammation—Doxorubicin—pancreatic cancer	0.00323	0.00323	CcSEcCtD
Lincomycin—Pain—Erlotinib—pancreatic cancer	0.0032	0.0032	CcSEcCtD
Lincomycin—Shock—Sunitinib—pancreatic cancer	0.00319	0.00319	CcSEcCtD
Lincomycin—Oesophagitis—Epirubicin—pancreatic cancer	0.00319	0.00319	CcSEcCtD
Lincomycin—Colitis—Doxorubicin—pancreatic cancer	0.0031	0.0031	CcSEcCtD
Lincomycin—Pancytopenia—Docetaxel—pancreatic cancer	0.00308	0.00308	CcSEcCtD
Lincomycin—Vaginal infection—Doxorubicin—pancreatic cancer	0.00305	0.00305	CcSEcCtD
Lincomycin—Neutropenia—Docetaxel—pancreatic cancer	0.00304	0.00304	CcSEcCtD
Lincomycin—Aplastic anaemia—Doxorubicin—pancreatic cancer	0.00303	0.00303	CcSEcCtD
Lincomycin—Urticaria—Tamoxifen—pancreatic cancer	0.00301	0.00301	CcSEcCtD
Lincomycin—Abdominal pain—Tamoxifen—pancreatic cancer	0.00299	0.00299	CcSEcCtD
Lincomycin—Body temperature increased—Erlotinib—pancreatic cancer	0.00296	0.00296	CcSEcCtD
Lincomycin—Abdominal pain—Erlotinib—pancreatic cancer	0.00296	0.00296	CcSEcCtD
Lincomycin—Oesophagitis—Doxorubicin—pancreatic cancer	0.00295	0.00295	CcSEcCtD
Lincomycin—Phlebitis—Epirubicin—pancreatic cancer	0.00294	0.00294	CcSEcCtD
Lincomycin—Vertigo—Irinotecan—pancreatic cancer	0.00294	0.00294	CcSEcCtD
Lincomycin—Leukopenia—Irinotecan—pancreatic cancer	0.00293	0.00293	CcSEcCtD
Lincomycin—Thrombophlebitis—Epirubicin—pancreatic cancer	0.00293	0.00293	CcSEcCtD
Lincomycin—Hepatic function abnormal—Epirubicin—pancreatic cancer	0.0029	0.0029	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.00287	0.00287	CcSEcCtD
Lincomycin—Leukopenia—Gemcitabine—pancreatic cancer	0.00285	0.00285	CcSEcCtD
Lincomycin—Jaundice—Docetaxel—pancreatic cancer	0.00282	0.00282	CcSEcCtD
Lincomycin—Stomatitis—Docetaxel—pancreatic cancer	0.00282	0.00282	CcSEcCtD
Lincomycin—Leukopenia—Fluorouracil—pancreatic cancer	0.00281	0.00281	CcSEcCtD
Lincomycin—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00279	0.00279	CcSEcCtD
Lincomycin—Pain—Sunitinib—pancreatic cancer	0.00277	0.00277	CcSEcCtD
Lincomycin—Phlebitis—Doxorubicin—pancreatic cancer	0.00272	0.00272	CcSEcCtD
Lincomycin—Thrombophlebitis—Doxorubicin—pancreatic cancer	0.00271	0.00271	CcSEcCtD
Lincomycin—Agranulocytosis—Docetaxel—pancreatic cancer	0.0027	0.0027	CcSEcCtD
Lincomycin—Hepatic function abnormal—Doxorubicin—pancreatic cancer	0.00268	0.00268	CcSEcCtD
Lincomycin—Pruritus—Tamoxifen—pancreatic cancer	0.00268	0.00268	CcSEcCtD
Lincomycin—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00267	0.00267	CcSEcCtD
Lincomycin—Dermatitis bullous—Epirubicin—pancreatic cancer	0.00265	0.00265	CcSEcCtD
Lincomycin—Pruritus—Erlotinib—pancreatic cancer	0.00265	0.00265	CcSEcCtD
Lincomycin—Shock—Irinotecan—pancreatic cancer	0.00263	0.00263	CcSEcCtD
Lincomycin—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.0026	0.0026	CcSEcCtD
Lincomycin—Diarrhoea—Tamoxifen—pancreatic cancer	0.00259	0.00259	CcSEcCtD
Lincomycin—Abdominal pain—Sunitinib—pancreatic cancer	0.00256	0.00256	CcSEcCtD
Lincomycin—Body temperature increased—Sunitinib—pancreatic cancer	0.00256	0.00256	CcSEcCtD
Lincomycin—Diarrhoea—Erlotinib—pancreatic cancer	0.00256	0.00256	CcSEcCtD
Lincomycin—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00256	0.00256	CcSEcCtD
Lincomycin—Hypotension—Irinotecan—pancreatic cancer	0.0025	0.0025	CcSEcCtD
Lincomycin—Erythema multiforme—Docetaxel—pancreatic cancer	0.00246	0.00246	CcSEcCtD
Lincomycin—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.00245	0.00245	CcSEcCtD
Lincomycin—Hypotension—Gemcitabine—pancreatic cancer	0.00243	0.00243	CcSEcCtD
Lincomycin—Vomiting—Tamoxifen—pancreatic cancer	0.00241	0.00241	CcSEcCtD
Lincomycin—Hypotension—Fluorouracil—pancreatic cancer	0.00239	0.00239	CcSEcCtD
Lincomycin—Hypersensitivity—Sunitinib—pancreatic cancer	0.00239	0.00239	CcSEcCtD
Lincomycin—Rash—Tamoxifen—pancreatic cancer	0.00239	0.00239	CcSEcCtD
Lincomycin—Dermatitis—Tamoxifen—pancreatic cancer	0.00239	0.00239	CcSEcCtD
Lincomycin—Vomiting—Erlotinib—pancreatic cancer	0.00238	0.00238	CcSEcCtD
Lincomycin—Rash—Erlotinib—pancreatic cancer	0.00236	0.00236	CcSEcCtD
Lincomycin—Dermatitis—Erlotinib—pancreatic cancer	0.00236	0.00236	CcSEcCtD
Lincomycin—Liver function test abnormal—Epirubicin—pancreatic cancer	0.00234	0.00234	CcSEcCtD
Lincomycin—Pruritus—Sunitinib—pancreatic cancer	0.00229	0.00229	CcSEcCtD
Lincomycin—Pain—Irinotecan—pancreatic cancer	0.00228	0.00228	CcSEcCtD
Lincomycin—Nausea—Tamoxifen—pancreatic cancer	0.00225	0.00225	CcSEcCtD
Lincomycin—Pain—Gemcitabine—pancreatic cancer	0.00223	0.00223	CcSEcCtD
Lincomycin—Nausea—Erlotinib—pancreatic cancer	0.00223	0.00223	CcSEcCtD
Lincomycin—Diarrhoea—Sunitinib—pancreatic cancer	0.00222	0.00222	CcSEcCtD
Lincomycin—Pain—Fluorouracil—pancreatic cancer	0.00219	0.00219	CcSEcCtD
Lincomycin—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.00217	0.00217	CcSEcCtD
Lincomycin—Abdominal pain—Irinotecan—pancreatic cancer	0.00211	0.00211	CcSEcCtD
Lincomycin—Body temperature increased—Irinotecan—pancreatic cancer	0.00211	0.00211	CcSEcCtD
Lincomycin—Pancytopenia—Epirubicin—pancreatic cancer	0.00208	0.00208	CcSEcCtD
Lincomycin—Vomiting—Sunitinib—pancreatic cancer	0.00206	0.00206	CcSEcCtD
Lincomycin—Body temperature increased—Gemcitabine—pancreatic cancer	0.00206	0.00206	CcSEcCtD
Lincomycin—Neutropenia—Epirubicin—pancreatic cancer	0.00205	0.00205	CcSEcCtD
Lincomycin—Rash—Sunitinib—pancreatic cancer	0.00204	0.00204	CcSEcCtD
Lincomycin—Dermatitis—Sunitinib—pancreatic cancer	0.00204	0.00204	CcSEcCtD
Lincomycin—Urticaria—Fluorouracil—pancreatic cancer	0.00203	0.00203	CcSEcCtD
Lincomycin—Leukopenia—Docetaxel—pancreatic cancer	0.00203	0.00203	CcSEcCtD
Lincomycin—Body temperature increased—Fluorouracil—pancreatic cancer	0.00202	0.00202	CcSEcCtD
Lincomycin—Hypersensitivity—Irinotecan—pancreatic cancer	0.00197	0.00197	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.00194	0.00194	CcSEcCtD
Lincomycin—Nausea—Sunitinib—pancreatic cancer	0.00193	0.00193	CcSEcCtD
Lincomycin—Pancytopenia—Doxorubicin—pancreatic cancer	0.00192	0.00192	CcSEcCtD
Lincomycin—Stomatitis—Epirubicin—pancreatic cancer	0.0019	0.0019	CcSEcCtD
Lincomycin—Jaundice—Epirubicin—pancreatic cancer	0.0019	0.0019	CcSEcCtD
Lincomycin—Neutropenia—Doxorubicin—pancreatic cancer	0.0019	0.0019	CcSEcCtD
Lincomycin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00189	0.00189	CcSEcCtD
Lincomycin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00185	0.00185	CcSEcCtD
Lincomycin—Pruritus—Gemcitabine—pancreatic cancer	0.00184	0.00184	CcSEcCtD
Lincomycin—Diarrhoea—Irinotecan—pancreatic cancer	0.00183	0.00183	CcSEcCtD
Lincomycin—Agranulocytosis—Epirubicin—pancreatic cancer	0.00182	0.00182	CcSEcCtD
Lincomycin—Shock—Docetaxel—pancreatic cancer	0.00182	0.00182	CcSEcCtD
Lincomycin—Pruritus—Fluorouracil—pancreatic cancer	0.00181	0.00181	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.00179	0.00179	CcSEcCtD
Lincomycin—Diarrhoea—Gemcitabine—pancreatic cancer	0.00178	0.00178	CcSEcCtD
Lincomycin—Jaundice—Doxorubicin—pancreatic cancer	0.00176	0.00176	CcSEcCtD
Lincomycin—Stomatitis—Doxorubicin—pancreatic cancer	0.00176	0.00176	CcSEcCtD
Lincomycin—Diarrhoea—Fluorouracil—pancreatic cancer	0.00175	0.00175	CcSEcCtD
Lincomycin—Hypotension—Docetaxel—pancreatic cancer	0.00173	0.00173	CcSEcCtD
Lincomycin—Vomiting—Irinotecan—pancreatic cancer	0.0017	0.0017	CcSEcCtD
Lincomycin—Agranulocytosis—Doxorubicin—pancreatic cancer	0.00169	0.00169	CcSEcCtD
Lincomycin—Rash—Irinotecan—pancreatic cancer	0.00168	0.00168	CcSEcCtD
Lincomycin—Dermatitis—Irinotecan—pancreatic cancer	0.00168	0.00168	CcSEcCtD
Lincomycin—Erythema multiforme—Epirubicin—pancreatic cancer	0.00166	0.00166	CcSEcCtD
Lincomycin—Vomiting—Gemcitabine—pancreatic cancer	0.00165	0.00165	CcSEcCtD
Lincomycin—Rash—Gemcitabine—pancreatic cancer	0.00164	0.00164	CcSEcCtD
Lincomycin—Dermatitis—Gemcitabine—pancreatic cancer	0.00164	0.00164	CcSEcCtD
Lincomycin—Tinnitus—Epirubicin—pancreatic cancer	0.00163	0.00163	CcSEcCtD
Lincomycin—Vomiting—Fluorouracil—pancreatic cancer	0.00163	0.00163	CcSEcCtD
Lincomycin—Rash—Fluorouracil—pancreatic cancer	0.00161	0.00161	CcSEcCtD
Lincomycin—Dermatitis—Fluorouracil—pancreatic cancer	0.00161	0.00161	CcSEcCtD
Lincomycin—Nausea—Irinotecan—pancreatic cancer	0.00159	0.00159	CcSEcCtD
Lincomycin—Pain—Docetaxel—pancreatic cancer	0.00158	0.00158	CcSEcCtD
Lincomycin—Nausea—Gemcitabine—pancreatic cancer	0.00155	0.00155	CcSEcCtD
Lincomycin—Erythema multiforme—Doxorubicin—pancreatic cancer	0.00153	0.00153	CcSEcCtD
Lincomycin—Nausea—Fluorouracil—pancreatic cancer	0.00152	0.00152	CcSEcCtD
Lincomycin—Tinnitus—Doxorubicin—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Lincomycin—Abdominal pain—Docetaxel—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Lincomycin—Body temperature increased—Docetaxel—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Lincomycin—Vertigo—Epirubicin—pancreatic cancer	0.00137	0.00137	CcSEcCtD
Lincomycin—Leukopenia—Epirubicin—pancreatic cancer	0.00137	0.00137	CcSEcCtD
Lincomycin—Hypersensitivity—Docetaxel—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Lincomycin—Pruritus—Docetaxel—pancreatic cancer	0.00131	0.00131	CcSEcCtD
Lincomycin—Vertigo—Doxorubicin—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Lincomycin—Leukopenia—Doxorubicin—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Lincomycin—Diarrhoea—Docetaxel—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Lincomycin—Anaphylactic shock—Epirubicin—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Lincomycin—Shock—Epirubicin—pancreatic cancer	0.00123	0.00123	CcSEcCtD
Lincomycin—Vomiting—Docetaxel—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Lincomycin—Rash—Docetaxel—pancreatic cancer	0.00116	0.00116	CcSEcCtD
Lincomycin—Hypotension—Epirubicin—pancreatic cancer	0.00116	0.00116	CcSEcCtD
Lincomycin—Dermatitis—Docetaxel—pancreatic cancer	0.00116	0.00116	CcSEcCtD
Lincomycin—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Lincomycin—Shock—Doxorubicin—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Lincomycin—Nausea—Docetaxel—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Lincomycin—Hypotension—Doxorubicin—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Lincomycin—Pain—Epirubicin—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Lincomycin—Urticaria—Epirubicin—pancreatic cancer	0.00099	0.00099	CcSEcCtD
Lincomycin—Pain—Doxorubicin—pancreatic cancer	0.000986	0.000986	CcSEcCtD
Lincomycin—Body temperature increased—Epirubicin—pancreatic cancer	0.000985	0.000985	CcSEcCtD
Lincomycin—Abdominal pain—Epirubicin—pancreatic cancer	0.000985	0.000985	CcSEcCtD
Lincomycin—Hypersensitivity—Epirubicin—pancreatic cancer	0.000918	0.000918	CcSEcCtD
Lincomycin—Urticaria—Doxorubicin—pancreatic cancer	0.000916	0.000916	CcSEcCtD
Lincomycin—Abdominal pain—Doxorubicin—pancreatic cancer	0.000911	0.000911	CcSEcCtD
Lincomycin—Body temperature increased—Doxorubicin—pancreatic cancer	0.000911	0.000911	CcSEcCtD
Lincomycin—Pruritus—Epirubicin—pancreatic cancer	0.000881	0.000881	CcSEcCtD
Lincomycin—Diarrhoea—Epirubicin—pancreatic cancer	0.000852	0.000852	CcSEcCtD
Lincomycin—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000849	0.000849	CcSEcCtD
Lincomycin—Pruritus—Doxorubicin—pancreatic cancer	0.000815	0.000815	CcSEcCtD
Lincomycin—Vomiting—Epirubicin—pancreatic cancer	0.000792	0.000792	CcSEcCtD
Lincomycin—Diarrhoea—Doxorubicin—pancreatic cancer	0.000789	0.000789	CcSEcCtD
Lincomycin—Rash—Epirubicin—pancreatic cancer	0.000785	0.000785	CcSEcCtD
Lincomycin—Dermatitis—Epirubicin—pancreatic cancer	0.000785	0.000785	CcSEcCtD
Lincomycin—Nausea—Epirubicin—pancreatic cancer	0.00074	0.00074	CcSEcCtD
Lincomycin—Vomiting—Doxorubicin—pancreatic cancer	0.000733	0.000733	CcSEcCtD
Lincomycin—Rash—Doxorubicin—pancreatic cancer	0.000727	0.000727	CcSEcCtD
Lincomycin—Dermatitis—Doxorubicin—pancreatic cancer	0.000726	0.000726	CcSEcCtD
Lincomycin—Nausea—Doxorubicin—pancreatic cancer	0.000685	0.000685	CcSEcCtD
